Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEagle Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/09/2023 | Q2 2023 | $0.39 | $64.65 M | |||
| 05/09/2023 | Q1 2023 | $1.19 | $0.44 | -0.75 | $66.31 M | |
| 03/23/2023 | Q4 2022 | $0.63 | $60.70 M | |||
| 11/09/2022 | Q3 2022 | -$0.27 | $65.90 M | |||
| 08/09/2022 | Q2 2022 | $3.13 | -$0.74 | -3.87 | $74.14 M | |
| 05/09/2022 | Q1 2022 | $3.88 | $3.47 | -0.41 | $115.87 M | |
| 03/07/2022 | Q4 2021 | -$0.48 | $42.32 M | |||
| 11/09/2021 | Q3 2021 | $0.87 | -$0.43 | -1.3 | $39.85 M | |
| 08/09/2021 | Q2 2021 | $0.88 | $0.28 | -0.6 | $48.12 M | |
| 05/10/2021 | Q1 2021 | $0.72 | -$0.03 | -0.75 | $41.25 M | |
| 03/05/2021 | Q4 2020 | $0.60 | $49.92 M | |||
| 11/02/2020 | Q3 2020 | $0.29 | $0.52 | 0.23 | $49.93 M | |
| 08/10/2020 | Q2 2020 | $0.14 | -$0.02 | -0.16 | $41.94 M | |
| 05/11/2020 | Q1 2020 | $0.47 | -$0.21 | -0.68 | $46.02 M | |
| 03/02/2020 | Q4 2019 | $0.35 | $0.07 | -0.28 | $48.26 M | |
| 11/12/2019 | Q3 2019 | $0.31 | -$0.17 | -0.48 | $41.15 M | |
| 08/08/2019 | Q2 2019 | $0.72 | $0.49 | -0.23 | $56.70 M | |
| 05/07/2019 | Q1 2019 | $0.57 | $0.64 | 0.07 | $49.79 M | |
| 02/28/2019 | Q4 2018 | $0.96 | $0.88 | -0.08 | $56.05 M | |
| 11/01/2018 | Q3 2018 | $0.98 | $0.94 | -0.04 | $51.34 M |
Eagle Pharmaceuticals, Inc. Earnings: FAQ's
When is Eagle Pharmaceuticals, Inc.'s earnings date?
Eagle Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 15th, 2024 based off last year's report dates.
How can I listen to Eagle Pharmaceuticals, Inc.'s earnings conference
call?
The conference call for Eagle Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
How can I read Eagle Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Eagle Pharmaceuticals, Inc.'s latest earnings report can be read online.
How much revenue does Eagle Pharmaceuticals, Inc. generate each year?
Eagle Pharmaceuticals, Inc. (:EGRX) has a recorded annual revenue of $316.61 M.
How much profit does Eagle Pharmaceuticals, Inc. generate each year?
Eagle Pharmaceuticals, Inc. (:EGRX) has a recorded net income of $316.61 M. Eagle Pharmaceuticals, Inc. has generated $2.76 earnings per share over the last four quarters.
What is Eagle Pharmaceuticals, Inc.'s price-to-earnings ratio?
Eagle Pharmaceuticals, Inc. (:EGRX) has a price-to-earnings ratio of 0.18 and price/earnings-to-growth ratio is 0.